RP3 clinical trials

Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours

This study is testing a new treatment called RP3, alone and with another drug called Nivolumab, for advanced cancers. It aims to find out if RP3 is safe and how much to give for future studies.